CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020 Aug 11, 2020 8:00am EDT
CNS Pharmaceuticals Completes Drug Product Manufacturing Strategy for Berubicin Jul 15, 2020 8:00am EDT
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin Jun 11, 2020 8:00am EDT
CNS Pharmaceuticals Announces Sponsored Research Agreement with MD Anderson for Potential Cancer Treatment Technologies May 28, 2020 8:00am EDT
